392 related articles for article (PubMed ID: 29357881)
1. Physical exercise, gut, gut microbiota, and atherosclerotic cardiovascular diseases.
Chen J; Guo Y; Gui Y; Xu D
Lipids Health Dis; 2018 Jan; 17(1):17. PubMed ID: 29357881
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiota and Heart, Vascular Injury.
Zeng C; Tan H
Adv Exp Med Biol; 2020; 1238():107-141. PubMed ID: 32323183
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota and atherosclerosis: role of B cell for atherosclerosis focusing on the gut-immune-B2 cell axis.
Chen L; Ishigami T; Doi H; Arakawa K; Tamura K
J Mol Med (Berl); 2020 Sep; 98(9):1235-1244. PubMed ID: 32737524
[TBL] [Abstract][Full Text] [Related]
4. Could physical exercise help modulate the gut microbiota in chronic kidney disease?
Esgalhado M; Borges NA; Mafra D
Future Microbiol; 2016 May; 11():699-707. PubMed ID: 27159232
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiota and Its Metabolites in Atherosclerosis Development.
Pieczynska MD; Yang Y; Petrykowski S; Horbanczuk OK; Atanasov AG; Horbanczuk JO
Molecules; 2020 Jan; 25(3):. PubMed ID: 32013236
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiome as a novel cardiovascular therapeutic target.
Singh V; Yeoh BS; Vijay-Kumar M
Curr Opin Pharmacol; 2016 Apr; 27():8-12. PubMed ID: 26828626
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiota: A New Marker of Cardiovascular Disease.
Garcia-Rios A; Torres-Peña JD; Perez-Jimenez F; Perez-Martinez P
Curr Pharm Des; 2017; 23(22):3233-3238. PubMed ID: 28317481
[TBL] [Abstract][Full Text] [Related]
8. The Relationship among Physical Activity, Intestinal Flora, and Cardiovascular Disease.
Yan Q; Zhai W; Yang C; Li Z; Mao L; Zhao M; Wu X
Cardiovasc Ther; 2021; 2021():3364418. PubMed ID: 34729078
[TBL] [Abstract][Full Text] [Related]
9. Role of gut microbiota in atherosclerosis.
Jonsson AL; Bäckhed F
Nat Rev Cardiol; 2017 Feb; 14(2):79-87. PubMed ID: 27905479
[TBL] [Abstract][Full Text] [Related]
10. Vegetarian diets and gut microbiota: important shifts in markers of metabolism and cardiovascular disease.
do Rosario VA; Fernandes R; Trindade EB
Nutr Rev; 2016 Jul; 74(7):444-54. PubMed ID: 27261272
[TBL] [Abstract][Full Text] [Related]
11. Microbiota and HDL metabolism.
Nakaya K; Ikewaki K
Curr Opin Lipidol; 2018 Feb; 29(1):18-23. PubMed ID: 29135690
[TBL] [Abstract][Full Text] [Related]
12. Exercise has the guts: How physical activity may positively modulate gut microbiota in chronic and immune-based diseases.
Codella R; Luzi L; Terruzzi I
Dig Liver Dis; 2018 Apr; 50(4):331-341. PubMed ID: 29233686
[TBL] [Abstract][Full Text] [Related]
13. [Host-microbiota crosstalk and cardiovascular diseases].
Amar J
Presse Med; 2018 Sep; 47(9):775-779. PubMed ID: 29909161
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiome as a biomarker of cardiometabolic disorders.
Gózd-Barszczewska A; Kozioł-Montewka M; Barszczewski P; Młodzińska A; Humińska K
Ann Agric Environ Med; 2017 Sep; 24(3):416-422. PubMed ID: 28954482
[TBL] [Abstract][Full Text] [Related]
15. [The relationship between gut microbiota and cardiovascular diseases].
Gerardi V; Del Zompo F; D'Aversa F; Gasbarrini A
G Ital Cardiol (Rome); 2016 Jan; 17(1):11-4. PubMed ID: 26901254
[TBL] [Abstract][Full Text] [Related]
16. The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease.
Ascher S; Reinhardt C
Eur J Immunol; 2018 Apr; 48(4):564-575. PubMed ID: 29230812
[TBL] [Abstract][Full Text] [Related]
17. Intestinal Immunity and Gut Microbiota in Atherogenesis.
Yamashita T
J Atheroscler Thromb; 2017 Feb; 24(2):110-119. PubMed ID: 27928097
[TBL] [Abstract][Full Text] [Related]
18. Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: a systematic review of human studies.
van den Munckhof ICL; Kurilshikov A; Ter Horst R; Riksen NP; Joosten LAB; Zhernakova A; Fu J; Keating ST; Netea MG; de Graaf J; Rutten JHW
Obes Rev; 2018 Dec; 19(12):1719-1734. PubMed ID: 30144260
[TBL] [Abstract][Full Text] [Related]
19. Gut Molecules in Cardiometabolic Diseases: The Mechanisms behind the Story.
Inceu AI; Neag MA; Craciun AE; Buzoianu AD
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834796
[TBL] [Abstract][Full Text] [Related]
20. Intestinal Immunity and Gut Microbiota as Therapeutic Targets for Preventing Atherosclerotic Cardiovascular Diseases.
Yamashita T; Kasahara K; Emoto T; Matsumoto T; Mizoguchi T; Kitano N; Sasaki N; Hirata K
Circ J; 2015; 79(9):1882-90. PubMed ID: 26212124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
